<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><description>BiG，Biologics Innovation Group是由致力于从事生物医药领域研究、开发、应用、临床、投资等工作的独立个人，自愿组织的一个专业/非盈利性机构。正式成立于2014年，迄今会员490余人，相继举办20余场行业峰会。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 25 Jan 2021 20:57:43 +0800</pubDate><image><url>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</url><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Nature Cancer｜新型ADC：Bolt Bio公司ISACs</title><link>https://mp.weixin.qq.com/s/GPjMctX-31whm08tADGvWw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwStxMluO8icH7RL4ezqI31N0DC1aS77nHVFqibU6g9TjxzfMd4nKXwJJg4fyyaMjF2hWyWc6VpWvHxg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>APCs活化，FcγR活性，抗体靶向三种优势融为一体。]]></content:encoded><pubDate>Mon, 25 Jan 2021 17:01:35 +0800</pubDate></item><item><title>荐 | 保护药品研发成果，这2项专利制度你必须知道！</title><link>https://mp.weixin.qq.com/s/lxTPJxhmi2pTycA7vFqS3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwTPFuZd7DYc6bvL4JopEa75LpF3y2DLiaGz2f1ZHYGSbgrNaZ7ReLdibwCk43gicgWMSicib132heFKgcg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>资深律师为你解析药品专利制度]]></content:encoded><pubDate>Mon, 25 Jan 2021 17:01:35 +0800</pubDate></item><item><title>盘点｜肿瘤干细胞药物开发的四条通路及主要靶点！</title><link>https://mp.weixin.qq.com/s/e_cvInoUSPsnN14ZDnskvw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwStxMluO8icH7RL4ezqI31N0WADL2pxPxgnicqUkGibfzkKKzvhc4dm5KEqpEJhibgAURFyTq3XfN4JZA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Notch、WNT、HH和Hippo通路]]></content:encoded><pubDate>Fri, 22 Jan 2021 15:48:53 +0800</pubDate></item><item><title>新江湖｜徐琦、刘佳凝、朱枫、郎帼娜、张妍加入BiG！</title><link>https://mp.weixin.qq.com/s/409dsez7olZOYA6cYjrWxQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwSd65jkQyiadDLWiaoQbibbLArpJsH949hguaqzdKTjZIH6yjD8AWCbWLNpg6icRY4sGiaWiayJydrbibJxA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>携手同行，共建Biologics闭环新江湖！]]></content:encoded><pubDate>Fri, 22 Jan 2021 15:48:53 +0800</pubDate></item><item><title>又一重磅Deal, 科望医药1.17亿美元引入VEGF/DLL4双抗！</title><link>https://mp.weixin.qq.com/s/8oFUIgWiSOFLQfIT4OQ-Jg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwR5JeoUkJXC62jriaOnjkdHhpJqEiaG2cB0T97rgf0w6qoJdoXWcOnX0sicVjicmCQEFb1Q0aGXsY6Cow/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>加码对抗“冷肿瘤”布局。]]></content:encoded><pubDate>Thu, 21 Jan 2021 13:00:35 +0800</pubDate></item><item><title>五位大咖谈IO｜单抗/ADC赛道，新靶点如何困境突围？</title><link>https://mp.weixin.qq.com/s/g1qSsbCfB4nXK9KEUGdRMA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwQvafRQp9320iaOJdJx0ibVKDnyVSsPAzjgcErBUbgqt6nFKJ2I5O1hiavCL8pFIyj8picopo3xblpvng/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>下一个IO的突破，来自哪里？]]></content:encoded><pubDate>Tue, 19 Jan 2021 17:00:05 +0800</pubDate></item><item><title>新江湖｜自贸壹号加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/nT6b1qb23k0zea_VOA6jBg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwRsQYALDMibqjwx2GOtTHHhS7uREtOcWAOAjibHzSnKSfyehUn9tI2xJsAAtCq5gkibCXIMH7EBIHiajA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Scientific Driven, Making Impact.]]></content:encoded><pubDate>Tue, 19 Jan 2021 17:00:05 +0800</pubDate></item><item><title>阿斯利康PD-1/CTLA-4双抗，增强对PD-1+活化T细胞CTLA-4的阻断作用</title><link>https://mp.weixin.qq.com/s/BogmE5ys86BAHGRJspYqyg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwTehyFTYIticDwG6JmLyTkRbIGFybJw5o4rW7DrqItwyWgoXjicAlD5svRMg5xbV1U8X2OlLFuc5qVA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>I期临床研究数据。]]></content:encoded><pubDate>Fri, 15 Jan 2021 17:00:59 +0800</pubDate></item><item><title>五位大咖谈CAR-T｜成本及定价，降VS不降，谁说了算？</title><link>https://mp.weixin.qq.com/s/GHuZBr3dwkN7nW3HAw6a7g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwSZRkykbdy3JWsqibsVtVNFlbZS8yIfCnbK6XbAOEHdOvbhQOsEIEWG4KHe9X7D7o9Tmqu1c8SjcCg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>上市前的产品定价和药费支付方式探讨]]></content:encoded><pubDate>Thu, 14 Jan 2021 07:52:29 +0800</pubDate></item><item><title>邀 | Biofuture 2021 下一代抗体药技术创新大会 &amp; 细胞与基因治疗创新大会</title><link>https://mp.weixin.qq.com/s/4eQX39EgvSm1umnXuCrBoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwSZRkykbdy3JWsqibsVtVNFlP1gibAJSQ158fTeOdPhYm82n5P5B24BficE51RiaicpgkAy2dTib3OGvaCQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Biofuture 2021 千人大会聚焦生物医药产业未来发展]]></content:encoded><pubDate>Thu, 14 Jan 2021 07:52:29 +0800</pubDate></item><item><title>盘点！靶向细胞凋亡的药物开发</title><link>https://mp.weixin.qq.com/s/34NGlF38QEReOzRRljj_Sw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwQZCuOy0ckiaUicMRyRVbDes8oNIxmSPypMeXYl2h43xiccrAx987IOdWdJqLumPmaSnNDWSicgVxuztA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>AbbVie/Amgen/亚盛医药等多家布局]]></content:encoded><pubDate>Tue, 12 Jan 2021 17:13:16 +0800</pubDate></item><item><title>新江湖｜娄实、戴晗、杨修诰、崔平、黄浩旻加入BiG！</title><link>https://mp.weixin.qq.com/s/ZEtBDFGdmiqeCVld_jGqhQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwSd65jkQyiadDLWiaoQbibbLArpJsH949hguaqzdKTjZIH6yjD8AWCbWLNpg6icRY4sGiaWiayJydrbibJxA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>携手同行，共建Biologics闭环新江湖！]]></content:encoded><pubDate>Tue, 12 Jan 2021 17:13:16 +0800</pubDate></item><item><title>新江湖｜阿诺医药加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/lEwTzKT-9aGD66EyS6bBmw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwRPGWpauM8efV9icZjnoAuicZCtV2sxRibjwibc2sp81CraIqib2DVb5KB8JQZZPUJzd8AsjfMGDmVOgYQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Scientific Driven, Making Impact.]]></content:encoded><pubDate>Tue, 12 Jan 2021 17:13:16 +0800</pubDate></item><item><title>千人在线！科学家创业会是中国FIC新药的答案么？</title><link>https://mp.weixin.qq.com/s/U0D3WN-AmwhF4tEaWlfD1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwTEzM6lic0Mm7nA8BGw0Aukhm23rNWXJ9IBfEr0JylZZg4SSJDDGaa51nAFjnf1N0hVOFOxxYSzgag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>从0到1，产学碰撞]]></content:encoded><pubDate>Sat, 09 Jan 2021 22:22:34 +0800</pubDate></item><item><title>邀丨会前通知，BIO APAC多的是你不知道的事！</title><link>https://mp.weixin.qq.com/s/lopL_-Xa6OGuEXfKhBBrJg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/29pUOme2eHJSxD0P3OISdhVN9r8fIecvoPxabpxtL1g1AdWyJTcSGWCzaclEONJuwzwFvWL0QDcPDjRAFjVHyw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>1月20-21日，中国上海]]></content:encoded><pubDate>Sat, 09 Jan 2021 22:22:34 +0800</pubDate></item><item><title>李金泽｜生物学驱动的CD3双抗一期临床开发</title><link>https://mp.weixin.qq.com/s/urCX9mIH_ce2lXZtwe2fqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwQeQJiay92pB7PhLfgxIq9wSJb6fc1uHReMjddDNWicMccoje7uO0vev578tProW5G1ZQ1pHR7tqkicg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>起始剂量和给药方案的关键点。]]></content:encoded><pubDate>Wed, 06 Jan 2021 17:37:03 +0800</pubDate></item><item><title>苏桥生物与非同生物就多个抗体创新生物药签署战略合作协议</title><link>https://mp.weixin.qq.com/s/vWx9j-M1qxJpxAgcdPCpQQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/huef9pbTc9a874pB5uCTNW64I4EKIQyoHadGrF4NvHEttsV5ysMlBpcbkI1UsOTh1IrUTBBlfmxRpMHc1jJicSQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>今日官宣！]]></content:encoded><pubDate>Wed, 06 Jan 2021 17:37:03 +0800</pubDate></item><item><title>简述四种NK细胞疗法耐药机制</title><link>https://mp.weixin.qq.com/s/6nFw2OvUTJhM7ByZPPtl7g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwT2lrVEHrAAeOjdmqSzGl08MSJH8qOSPtvDc1xeOLFm1dUFFsGvYqQxgjDCNwdqiaeTYtk5SW7LMBQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>遗传突变、免疫抑制、免疫编辑、Hallmarks…]]></content:encoded><pubDate>Wed, 06 Jan 2021 16:48:53 +0800</pubDate></item><item><title>周五直播｜科学家创业工作坊，你可能不知道的N个坑</title><link>https://mp.weixin.qq.com/s/oJ6tHBEqgQGgW2_aJsJVHw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/m6gqgND1GwQeQJiay92pB7PhLfgxIq9wSDxMziaJlibYwMB3Z5IWQxozj6sCzuTKNh1QaB3uVAibAZNXOzs7NzGrow/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>BiG X 新生巢，联合出品。]]></content:encoded><pubDate>Wed, 06 Jan 2021 16:48:53 +0800</pubDate></item></channel></rss>